World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
30045
World Ranking
11767
National Ranking
6035

Overview

Victor A. Levin is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research focuses primarily on medicine, with particular interest in genetics, modeling and simulation, pulmonary and respiratory medicine, cancer research, and molecular biology. The scientist's work covers various topics, notably glioma diagnosis and treatment, brain metastases and treatment, mathematical biology related to tumor growth, cancer, stress, anesthesia, and immune response, cancer genomics and diagnostics, medical imaging techniques and applications, as well as CRISPR and genetic engineering.

Their recent papers include:

  • Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to Overcome (2020), published in Frontiers in Oncology
  • Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02 (2020), published in Neuro-Oncology Advances
  • Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems Theory (2022), published in Neurotherapeutics
  • Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cells (2020), published in Oncotarget
  • LTBK-01. PHASE 3 STELLAR STUDY SHOWS EFLORNITHINE IMPROVES OVERALL SURVIVAL (OS) AND PROGRESSION FREE SURVIVAL (PFS) IN PATIENTS WITH RECURRENT 2021 WHO ASTROCYTOMA, IDH-MUTANT GRADE 3 (2024), published in Neuro-Oncology

Frequent co-authors of Victor A. Levin include:

  • Patrick Y. Wen
  • Timothy F. Cloughesy
  • Howard Colman
  • Tobias Walbert
  • Andrew B. Lassman

The scientist publishes regularly in the following venues:

  • Neuro-Oncology
  • Frontiers in Oncology
  • Neuro-Oncology Advances
  • Neurotherapeutics
  • Oncotarget

Best Publications

  • A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

    W K A Yung;R E Albright;J Olson;R Fredericks

  • Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

    Eric T. Wong;Kenneth R. Hess;Mary Jo Gleason;Kurt A. Jaeckle

  • RELATIONSHIP OF OCTANOL/WATER PARTITION COEFFICIENT AND MOLECULAR WEIGHT TO RAT BRAIN CAPILLARY PERMEABILITY

    V. A. Levin

  • A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

    Juan Fueyo;Candelaria Gomez-Manzano;Ramon Alemany;Polly S.Y. Lee

  • Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

    W. K.Alfred Yung;Michael D. Prados;Ricardo Yaya-Tur;Steven S. Rosenfeld

  • Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

    Ashok J Kumar;N. E. Leeds;Gregory N Fuller;P. Van Tassel

  • Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system

    Victor A. Levin;Luc Bidaut;Ping Hou;Ashok J Kumar

  • Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas

    Howard A. Fine;William D. Figg;Kurt Jaeckle;Patrick Y. Wen

  • The Functional Assessment of Cancer Therapy (FACT) Scale : development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors

    Michael A. Weitzner;Christina A. Meyers;K B A Cynthia Gelke;S B A Kevin Byrne

  • Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.

    Victor A. Levin;Pamela Silver;John Hannigan;William M. Wara

  • Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

    Patrick Y. Wen;W. K Alfred Yung;Kathleen R. Lamborn;Patricia L. Dahia

  • Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.

    Christina A. Meyers;Michael A. Weitzner;Alan D. Valentine;Victor A. Levin

  • Effect of bevacizumab on radiation necrosis of the brain

    Javier Gonzalez;Ashok J. Kumar;Charles A. Conrad;Victor A. Levin

  • Reoperation for Recurrent Glioblastoma and Anaplastic Astrocytoma

    Griffith R. Harsh;Victor A. Levin;Philip H. Gutin;Margaret Seager

  • Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis.

    Candelaria Gomez-Manzano;Juan Fueyo;Athanassios P. Kyritsis;Peter A. Steck

  • Cognitive Function as a Predictor of Survival in Patients With Recurrent Malignant Glioma

    Christina A. Meyers;Kenneth R. Hess;W.K. Alfred Yung;Victor A. Levin

  • Pineal region tumors in children.

    Michael S. B. Edwards;Roger J. Hudgins;Charles B. Wilson;Victor A. Levin

  • Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas

    Ali K. Choucair;Victor A. Levin;Philip H. Gutin;Richard L. Davis

  • Biology and treatment of malignant glioma.

    M D Prados;V Levin

  • Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources

    Philip H. Gutin;Theodore L. Phillips;William M. Wara;Steven A. Leibel

Frequent Co-Authors

Charles B. Wilson
Charles B. Wilson University of California, San Francisco
W. K. Alfred Yung
W. K. Alfred Yung The University of Texas MD Anderson Cancer Center
Michael S. B. Edwards
Michael S. B. Edwards Stanford University
Michael D. Prados
Michael D. Prados University of California, San Francisco
Kenneth R. Hess
Kenneth R. Hess The University of Texas MD Anderson Cancer Center
William M. Wara
William M. Wara Kaiser Permanente
Mark R. Gilbert
Mark R. Gilbert National Institutes of Health
Philip H. Gutin
Philip H. Gutin Memorial Sloan Kettering Cancer Center
Melissa L. Bondy
Melissa L. Bondy Stanford University
Richard L. Davis
Richard L. Davis University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medicine but considering alternative pathways or related healthcare roles? Online degrees have made it easier than ever to pursue nursing, advance your credentials, or transition into healthcare from another field—all with flexibility and affordability in mind.

Many students begin with entry-level nursing and look for the affordable rn to bsn programs to quickly upgrade their qualifications. For those prioritizing cost, exploring one of the cheapest bsn programs online is a smart starting point.

If you already hold a bachelor’s degree—in any subject—direct entry nurse practitioner programs for non-nurses online offer a streamlined path to advanced practice and leadership roles without repeating previous undergraduate work.

For nurses aiming for the highest qualifications, earning your online nursing doctorate can open doors to teaching, research, and executive careers in healthcare.

Whether you’re advancing within nursing or seeking flexible ways to enter the field, these online pathways provide a range of options to launch or accelerate your healthcare career.

Best Scientists Citing Victor A. Levin

Trending Scientists